Clinical trial
Biomarkers in Necrotizing Soft Tissue Infections - Effects of Hyperbaric Oxygen Treatment on the Immune Response
NCT02501382 is registered in ClinicalTrials.gov with Ole Hyldegaard as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biomarkers in Necrotizing Soft Tissue Infections - Effects of Hyperbaric Oxygen Treatment on the Immune Response
- Lead sponsor
- Ole Hyldegaard
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2013
- Completion date
- December 1, 2015
- Enrollment
- 65 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fournier gangrene, gas gangrene, necrotizing fasciitis, necrotizing soft tissue infection